CRISPR Therapeutics, MGH team up on new cancer treatments
CRISPR Therapeutics and Massachusetts General Hospital Cancer Center are teaming up to improve upon new cutting-edge treatments for cancer using gene editing.
CRISPR (Nasdaq: CRSP), which is headquartered in Switzerland but conducts research and development in Cambridge, Massachusetts, expects the two-year collaboration to help advance cancer treatments that harness the body’s own immune system.
One of the latest trends in biotech is so-called immuno therapies that take certain immune system cells,…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Jessica Bartlett Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Genetics | Health Management | Hospitals | Switzerland Health